BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28522645)

  • 1. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O; Snajderova M; Blair J; Pournara E; Pedersen BT; Petit IO
    Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Still too little, too late? Ten years of growth hormone therapy baseline data from the NordiNet® International Outcome Study.
    Polak M; Konrad D; Tønnes Pedersen B; Puras G; Šnajderová M
    J Pediatr Endocrinol Metab; 2018 Apr; 31(5):521-532. PubMed ID: 29652668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Growth Hormone Results in Different Diagnosis and Trend Over 10 Year of Follow-up: A Single Center Experience.
    Aycan Z; Araslı Yılmaz A; Yel S; Savaş-Erdeve Ş; Çetinkaya S
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):332-341. PubMed ID: 33749217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet® IOS and ANSWER Program.
    Sävendahl L; Polak M; Backeljauw P; Blair J; Miller BS; Rohrer TR; Pietropoli A; Ostrow V; Ross J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4730-4742. PubMed ID: 31305924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early growth hormone treatment start in childhood growth hormone deficiency improves near adult height: analysis from NordiNet® International Outcome Study.
    Polak M; Blair J; Kotnik P; Pournara E; Pedersen BT; Rohrer TR
    Eur J Endocrinol; 2017 Nov; 177(5):421-429. PubMed ID: 28780521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS).
    Pfäffle R; Land C; Schönau E; Holterhus PM; Ross JL; Piras de Oliveira C; Child CJ; Benabbad I; Jia N; Jung H; Blum WF
    Horm Res Paediatr; 2018; 90(3):169-180. PubMed ID: 30199857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI findings of the pituitary gland in short children born small for gestational age (SGA) in comparison with growth hormone-deficient (GHD) children and children with normal stature.
    Arends NJ; V d Lip W; Robben SG; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):719-24. PubMed ID: 12460320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
    Pfäffle R; Bidlingmaier M; Kreitschmann-Andermahr I; Land C; Partsch CJ; Schwab KO; Sommer H; Backeljauw P; Kanumakala S; Loche S; Zouater H; Strasburger CJ
    Horm Res Paediatr; 2020; 93(3):154-163. PubMed ID: 32814319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for Optimization of Growth Hormone Treatment in Children with Growth Hormone Deficiency, Small for Gestational Age, and Turner Syndrome in Germany: Data from the PATRO® Children Study.
    Partsch CJ; Land C; Pfäffle RW; Schwab KO; Sommer H;
    Horm Res Paediatr; 2024 Apr; ():1-11. PubMed ID: 38663373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Growth Hormone treatment in children with Growth Hormone deficiency, idiopathic short stature, SHOX gene mutation, small for gestational age and Turner syndrome].
    Griffero González M; González Navarrete D; Tolosa Navarro F; López Cuevas P; Rodríguez Convertino F; Román Reyes R
    Andes Pediatr; 2024 Apr; 95(2):151-158. PubMed ID: 38801362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER.
    Sävendahl L; Polak M; Backeljauw P; Blair JC; Miller BS; Rohrer TR; Hokken-Koelega A; Pietropoli A; Kelepouris N; Ross J
    J Clin Endocrinol Metab; 2021 May; 106(6):1728-1741. PubMed ID: 33571362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needle-Free and Needle-Based Growth Hormone Therapy in Children: A Pooled Analysis of Three Long-Term Observational Studies.
    Rohrer TR; Ceplis-Kastner S; Jorch N; Müller HL; Pfäffle R; Reinehr T; Richter-Unruh A; Weißenbacher C; Holterhus PM; Ferring Arzneimittel GmbH DSC
    Horm Res Paediatr; 2018; 90(6):393-406. PubMed ID: 30836359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of discontinuation of growth hormone treatment on lipids and weight status in adolescents.
    Rothermel J; Lass N; Bosse C; Reinehr T
    J Pediatr Endocrinol Metab; 2017 Jul; 30(7):749-757. PubMed ID: 28672749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet® IOS and Answer Program.
    Backeljauw P; Blair JC; Ferran JM; Kelepouris N; Miller BS; Pietropoli A; Polak M; Sävendahl L; Verlinde F; Rohrer TR
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2653-2665. PubMed ID: 36947589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study.
    Stevens A; Murray P; Wojcik J; Raelson J; Koledova E; Chatelain P; Clayton P;
    Eur J Endocrinol; 2016 Dec; 175(6):633-643. PubMed ID: 27651465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.